Objectives: The aims of the study were two-fold: (1) antigen (Ag) preparation and evaluation of three antigens of Gnathostoma spinigerum infective larvae (GsL3), crude somatic antigen (CSAg), excretory-secretory antigen (ESAg) and partially purified antigens (namely P1Ag, P2Ag and P3Ag) to differentiate IgE, IgG, IgG1-4 and IgM for human gnathostomiasis diagnosis; and (2) application of the selected ELISA for following up stored sera of patients treated with ivermectin (IVM) and albendazole (ABZ).

Methods: Different antigens were analysed by antibodies of gnathostomiasis cases, other parasite infections and healthy controls using indirect ELISA to differentiate IgE, IgG, IgG1-4 and IgM. Then, prominent antigen and immunoglobulin were used in antibody predictions of gnathostomiasis cases treated with albendazole or ivermectin.

Results: Sensitivity of all evaluated ELISAs: IgM-, IgG-, IgG1- and IgG4-ELISA, was 100%. IgM-ELISA with CSAg and P3Ag exhibited the highest specificity of 99%. IgG-ELISA with P2Ag resulted in the highest specificity of 92.3%. IgG1-ELISA with P2Ag and P3Ag showed excellent results with 100% specificity. Finally, P2Ag evaluated IgG1 of the followed-up cases with ABZ and IVM. Decreasing antibody IgG1 levels were mostly found in both treatments at Month 9 and long follow-up was over 12 months. A Gnathostoma worm was extracted from each two treated patients.

Conclusions: Using IgG1-ELISA against P2Ag and P3Ag gave excellent results with 100% sensitivity and specificity. These tests can be an alternative to immunoblotting for gnathostomiasis. IgG1 decreased at least 9 months in most cases, so long-term treatment should be performed over 1 year.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291276PMC
http://dx.doi.org/10.1111/tmi.13679DOI Listing

Publication Analysis

Top Keywords

igg igg1-4
12
p2ag p3ag
12
human gnathostomiasis
8
gnathostoma spinigerum
8
differentiate ige
8
ige igg
8
igg1-4 igm
8
gnathostomiasis cases
8
highest specificity
8
igg1-elisa p2ag
8

Similar Publications

Article Synopsis
  • - Neutralizing antibodies (NAbs) are crucial for vaccine protection against HPV, but the necessary levels for effective protection are still unknown.
  • - The study introduces a new multiplex bead-based immunoassay that can efficiently analyze antibody responses to multiple oncogenic HPV types found in the nonavalent HPV vaccine.
  • - This new assay is faster and uses fewer samples than the traditional HPV pseudovirion-based neutralization assay (PBNA), showing strong agreement with NAb results from the PBNA.
View Article and Find Full Text PDF

Background: Anti-IgLON5 disease is a rare chronic autoimmune disorder characterized by IgLON5 autoantibodies predominantly of the IgG4 subclass. Distinct pathogenic effects were described for anti-IgLON5 IgG1 and IgG4, however, with uncertain clinical relevance.

Methods: IgLON5-specific IgG1-4 levels were measured in 46 sera and 20 cerebrospinal fluid (CSF) samples from 13 HLA-subtyped anti-IgLON5 disease patients (six females, seven males) using flow cytometry.

View Article and Find Full Text PDF
Article Synopsis
  • Human IgG consists of four subclasses (IgG1-4), with IgG4 having a notably short hinge region and two glycan chains on its Fc subunit, the significance of which is not fully known.
  • A study compared the structure and stability of glycosylated and deglycosylated IgG4 A33, revealing that deglycosylation resulted in a monomeric form with minimal changes in overall structure as observed through various analytical techniques.
  • The findings suggest that while deglycosylated IgG4 exhibits greater conformational variability in its Fc structure compared to its glycosylated form, significant structural changes are more pronounced in IgG1 than in IgG4.
View Article and Find Full Text PDF

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a persistent environmental contaminant and high affinity ligand for the aryl hydrocarbon receptor (AhR). In animal models, AhR activation by TCDD generally inhibits antibody secretion. However, it is less clear if this translates to human antibody production.

View Article and Find Full Text PDF
Article Synopsis
  • Mycobacterium tuberculosis, which causes tuberculosis (TB), can affect various organs, including the brain, leading to a serious condition called TB meningitis (TBM), yet the immune mechanisms behind these differences in disease presentation are not fully understood.
  • Research has shifted focus from T cell responses to the role of antibodies in controlling M. tuberculosis, particularly looking at how these antibodies respond differently in the lungs versus the brain.
  • Using an advanced serology technique, the study analyzed antibody responses in TBM patients compared to those with pulmonary TB, revealing distinct profiles in the cerebrospinal fluid that highlight a unique immune response in TBM, potentially serving as markers for disease severity and prognosis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!